Under the terms of the deal Bridge Biotherapeutics will receive upfront and near term payments of 45 million Euros and is eligible to receive up to more than 1.1 billion Euros in potential payments.
19th July 2019
ALS is a progressive neurodegenerative disease that affects motor neuron cells in the brain and the spinal cord.
19th July 2019
The governing body accepted the company's Biologics License Application for prevention of vaso-occlusive crises.
18th July 2019
More than 85% of companies have no women executives on their main boards, only 9% of executive directors on main boards are women, and a mere 17% of FTSE350 executive committee members are women.
18th July 2019
During the pilot over the last seven months over 1,000 customers accessed the service, with the majority of them completing the service in the same day.
18th July 2019
The Mitomic Prostate Test has a 92% sensitivity, which means that men with a positive result can be referred for immediate medical intervention.
18th July 2019
The candidate, LYT-100, demonstrated anti-fibrotic and anti-inflammatory mechanisms in pre-clinical studies.
17th July 2019
AMAL’s lead vaccine, ATP128, is currently developed for stage IV colorectal cancer and is slated to begin first-in-human trials later this month.
17th July 2019
Under the terms of the agreement, Sosei Heptares is eligible to receive US$26 million in upfront and near-term payments.
17th July 2019
NICE has recommended Novartis’ Kisqali just three months after its initial rejection.
17th July 2019
The ‘toolkit’, will be available to help companies implement the FAIR guiding principles for data management and stewardship.
17th July 2019
A new ‘transfer window’ lets staff move within the NHS between areas while developing new skills.
16th July 2019
Financial terms of the transaction have not been disclosed and are expected to have a minimal impact on revenue and earnings in the current financial year.
16th July 2019
CAD is the most common type of heart disease in the United States, as up to one half of middle aged men and one third of middle aged women in the US are at risk of developing CAD during their lifetime.
16th July 2019
Decisions include restricting who can prescribe these medicines, making warnings on the packaging more prominent and providing educational materials.
16th July 2019
